|Drug (INN)*||Trade Name||Developer||FDA||Europe|
|Brentuximab Vedodin||Adcetris®||Seattle Genetics / Takeda||2011||2012|
* Link to drug description
** Link to package insert
Last Editorial Review: August 28, 2017
Copyright © 2017 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.